Development and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy

American Journal of Gastroenterology

Volumn 104, Issue 6, 2009, Pages 1508-1518

  Kastrinos, Fay ^a,b   Allen, John I ^c   Stockwell, David H ^a,d,e   Stoffel, Elena M ^a,d,f   Cook, Earl F ^d,g   Mutinga, Muthoka L ^d,e   Balmãa, Judith ^h   Syngal, Sapna ^a,d,f  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Department of Medicine   (United States)

^c Minnesota Gastroenterology   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e Brigham and Women's/Faulkner Hospitals   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; COLON CANCER; COLONOSCOPY; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; VALIDATION PROCESS;

COLONIC NEOPLASMS; COLONOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MORBIDITY; OUTPATIENTS; PILOT PROJECTS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES;

EID: 66949163334     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.135     Document Type: Article

References (42)

1. Imperiale T. Toward risk stratifcation for screening and surveillance of colorectal neoplasia: one small step for the colonoscopist . Gastroenterology 2007;133:1364-76.
2. Lieberman DA, de Garmo PL, Fleischer DE et al. Patterns of endoscopy use in the United States . Gastroenterology 2000;118:619-24.
3. Harewood GC, Lieberman DA. Colonoscopy practice patterns since introduction of medicare coverage for average-risk screening . Clin Gastroenterol Hepatol 2004;2:72-7.
4. Byers T, Levin B, Rothenberger D et al. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: update 1997 . CA Cancer J Clin 1997;47:154-60.
5. Jarvinen HJ, Aarnio M, Mustonen H et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000;18:829-34.
6. de Jong AE, Hendriks YM, Kleibeuker JH et al. Decrease in mortality in Lynch syndrome families because of surveillance . Gastroenterology 2006;130:665-71.
7. Heiskanen I, Luostarinen T, Jarvinen HJ. Impact of screening examinations on survival in familial adenomatous polyposis . Scand J Gastroenterol 2000;35:1284-7.
8. Vasen HFA, Mecklin JP, Meera Khan P et al. The international collaborative group on HNPCC . Dis Colon Rectum 1991;34:424-5.
9. Vasen HFA, Watson P, Mecklin JP et al. New criteria for HNPCC proposed by the ICG-HNPCC . Gastroenterology 1999;116:1453-6.
10. Rodriquez-Bigas MA, Boland CR, Hamilton SR et al. An NCI workshop on HNPCC: meeting highlights and Bethesda guidelines . J Natl Cancer Inst 1997;89:1758-62.
11. Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsat-ellite instability . J Natl Cancer Inst 2004;96:261-8.
12. Stofel E, Grover S, Russo L et al. Physician awareness of cancer screening recommendations for hereditary nonpolyposis colorectal cancer is limited . Gastroenterology 2003;124:A646 .
13. Stofel EM, Garber JE, Grover S et al. Cancer surveillance is ofen inadequate in individuals at high-risk for colorectal cancer. J Med Genet 2003;40:e54.
14. Giardiello FM, Bre nsinger JD, Petersen GM. AGA technical review on hereditary colorectal cancer and genetic testing . Gastroenterology 2001;12:195-213.
15. Ramsey SD, Clark L, Etzioni R et al. Cost-efectiveness of microsatellite instability screening as a method of detecting hereditary nonpolyposis colorectal cancer. Ann Intern Med 2001;135:577-88.
16. Kievit W, de Bruin JH, Adang EM et al. Cost-efectiveness of a new strategy to identify HNPCC patients . Gut 2005;54:97-102.
17. Grover S, Stofel EM, Syngal S et al. Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients . Clin Gastroenterol Hepatol 2004;2:813-9.
18. Raedle J, Trojan J, Brieger A et al. Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer. Ann Intern Med 2001;135:566-76.
19. Furukawa T, Konishi F, Shitoh K et al. Evaluation of screening strategy for detecting hereditary nonpolyposis colorectal carcinoma . Cancer 2002;94:91-20.
20. Pinol V, Castells A, Andreu M et al. Accuracy of revised Bethes da guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer . JAMA 2005;293:1986-94.
21. Breiman L, Freidman JH, Olshen RA et al. Classifcation and Regression Trees . Wadsworth International Group: Belmont, CA , 1984 .
22. Balmaña J, Stockwell DH, Steyerberg EW et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome . JAMA 2006;296:1469-78.
23. Selvachandran SN, Hodder RJ, Ballal MS et al. Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 2002;360:278-83.
24. Church JM. A scoring system for the strength of a family history of colorectal cancer. Dis Colon Rectum 2005;48:889-96.
25. Goldman L, Weinberg M, Weisberg M et al. A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain . N Engl J Med 1982;307:588-96.
26. Goldman L, Cook EF, Brand DA et al. A computer protocol to predict myocardial infarction in emergency department patients in chest pain . N Engl J Med 1988;318:797-803.
27. Temkin NR, Holubkov R, Machamer JE et al. Classifcation and regression trees (CART) for prediction of function at 1 year following head trauma . J Neurosurg 1995;82:764-71.
28. Garzotto M, Beer TM, Hudson G et al. Improved detection of prostate cancer using classification and regression tree analysis . J Clin Oncol 2005;23:4322-9.
29. Fonarow GC, Asams KF, Abraham WT et al. Risk stratifcation for inhospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 2005;293:572-80.
30. Murf HJ, Spigel DR, Syngal S. Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history . JAMA 2004;292:1480-9.
31. Douglas FS, O'Dair LC, Robinson M et al. The accuracy of diagnoses as reported in families with cancer: a retrospective study . J Med Genet 1999;36:309-12.
32. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer . J Chronic Dis 1985;38:289-93.
33. Sijmons RH, Boonstra AE, Reefhuis J et al. Accuracy of family history of cancer: clinical genetic implications . Eur J Hum Genet 2000;8:181-6.
34. Wijnen JT, Vasen HF, Khan PM et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer . N Engl J Med 1998;339:51-8.
35. Lipton LR, Johnson V, Cummings C et al. Refning the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol 2004;22:4934-43.
36. Barnetson RA, Tenesa A, Farrington SM et al. Identifcation and survival of carriers of mutations in DNA mismatch repair genes in colon cancers . N Engl J Med 2006;354:2751-63.
37. Chen S, Wang W, Lee S et al. Prediction of germline mutations and cancer risk in the Lynch syndrome . JAMA 2006;296:1479-87.
38. Balaguer F, Balmaña J, Castellvi-Bel S et al. Validation and extension of the PREMM1,2 model in a population-based cohort of colorectal cancer patients. Gastroenterology 2008;134:39-46.
39. Syngal S, Weeks JC, Schrag D et al. Benefts of colonoscopic surveillance and prophylactic colectomy in mutation carriers for hereditary nonpolyposis colorectal cancer . Ann Intern Med 1998;129:787-96.
40. Sweet KM, Bradley TL, Westman JA. Identifcation and referral of families at high risk for cancer susceptibility . J Clin Oncol 2002;20:528-37.
41. Lindor NM, Rabe K, Petersen GM et al. Lower cancer incidence in Amsterdam I criteria families without mismatch repair deficiency: familial colorectal cancer type X . JAMA 2005;293:1979-85.
42. Halbert CH, Lynch H, Lynch J et al. Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations . Arch Int Med 2004;164:1881-7.